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Abstract
Kidney injury associated with lymphocytic leukemia (CLL) is typically caused by direct tumor infiltration which
occasionally results in acute renal failure. Glomerular involvement presenting as proteinuria or even nephrotic
syndrome is exceptionally rare. Here we report a case of 54-year-old male CLL patient with nephrotic syndrome
and renal failure. The lymph node biopsy confirmed that the patients had CLL with remarkable immunoglobulin
light chain amyloid deposition. The renal biopsy demonstrated the concurrence of AL amyloidosis and neoplastic
infiltration. Combined treatment of fludarabine, cyclophosphamide and rituximab resulted in remission of CLL, as
well as the renal disfunction and nephrotic syndrome, without recurrence during a 12-month follow-up. To our
knowledge, this is the first case of CLL patient showing the nephrotic syndrome and acute renal failure caused by
AL amyloidosis and neoplastic infiltration. Though AL amyloidosis caused by plasma cell dyscrasia usually responses
poorly to chemotherapy, this patient exhibited a satisfactory clinical outcome due to successful inhibition of the
production of amylodogenic light chains by combined chemotherapy.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/2479639195566762.
Background
AL amyloidosis is characterized by widespread, progressive
deposition of amyloid fibrils derived from monoclonal
immunoglobulin (Ig) light chains, leading to multi-system
organ failure among which the kidneys and heart are most
frequently affected [1]. Although AL amyloidosis is typi-
cally caused by plasma cell proliferative disease especially
multiple myeloma, it can also be caused by other lympho-
proliferative disorders of B-cells such as lymphoplasmacy-
tic lymphoma, of which the neoplastic B cells produce
monoclonal immunoglobulin light chains [2]. Only few
cases of AL amyloidosis associated with chronic lympho-
cytic leukemia (CLL) have been reported [2-5]. Another
relatively common injury caused CLL is the direct neo-
plastic cell infiltration as demonstrated by autopsy studies
[6], but acute renal failure due to severe infiltration is rare
[7-9].
In this report, we present a patient with nephrotic syn-
drome and renal failure associated with CLL. The patient
completely recovered from the nephrotic syndrome and
renal dysfunction after CLL was controlled with che-
motherapy. We have reviewed the literature and dis-
cussed the relationship between CLL and amyloidosis
and the pathological implications.
Case presentation
Clinic data
A 54-year-old male Chinese patient was admitted to the
Shunde People’s hospital on March 7, 2008, complaining
of nocturia and edema of face and both lower extremities
for more than two months. The patient had no history of
any renal disease. Physical examinations revealed normal
vital signs, moderate hypertension (162/96 mmHg) and
pitting edema of the lower extremities. Enlargement of
lymph nodes involving inguinal, axillary, submaxillary and
supraclavicular fossa with a diameter of more than 1 cm
was found. The remainder of the examination was
unremarkable.
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Both his hemoglobin and erythrocyte count were in
normal range. The leukocytes increased to 16.8 × 109/L
with elevated lymphocytic proportion by 61.8% (normal
range: 24%-40%). Urine analysis showed proteinuria of
5 g/L with a RBC count of 150/μL. His 24-hour total
urinary protein excretion was 5.11 g and serum albumin
level was 38 g/L. The blood creatinine (Cr) concentra-
tion was 290.04 μmol/L (normal range: 53-115 umol/l)
and the urea nitrogen (BUN) was 13.49 mmol/L (normal
range: 2.9-8.6 mmol/l) indicating the impaired renal
function. Both Ig-M (kappa) monoclonal protein and
free kappa were detected in his serum by immunofixa-
tion electrophoresis, but urine Bence Jones protein was
negative. He also had high serum IgM concentration
(3.9 g/L, normal range: 0.50-2.20 g/L) while the IgG and
IgA levels were normal. The serum complement 3
decreased to 0.03 g/L (normal range: 0.79-1.17 g/l). The
tests for antinuclear antibody, rheumatoid factor, cryo-
globulin and hepatitis virus B and C all showed negative.
The bone marrow aspiration showed increased cellular-
ity and the accumulation of small immature-appearing
lymphocytes, without increase of plasma cells. Flow
cytometric analysis showed that those lymphocytes were
positive for CD5, CD19, CD20, HLA-DR, kappa and
surface membrane IgM, and negative for CD3, CD7,
CD10, CD38 and lambda (Figure 1). The CT scanning
revealed numerous intumesced lymph nodes in the
neck, thoracic cavity, celiac and retroperitoneal space
(Figure 2). Liver and spleen were both enlarged with
dense and fine sonogram. The echocardiography indi-
cated mildly and symmetrically thickened left ventricular
wall. The patient was diagnosed with acute renal failure
together with a nephrotic-range proteinuria.
Pathological findings
The biopsy from one of enlarged lymph nodes showed
effacement of the architecture with a dark background
of cells consisting of numerous small lymphocyte-like
cells with scattered larger cells including
prolymphocytes and paraimmunoblasts. The predomi-
nant cells were slightly larger than normal lymphocytes
(Figure 3A) with round nucleolus and clumped chroma-
tin. Only mild nuclear irregularity was noted. The mito-
tic phase was occasionally observed.
Immunohistochemistry showed these cells were positive
for CD20, CD79a, CD5 (Figure 3B), and CD23 but
negative for CD3, CD45RO, CyclinD1, CD38, and
CD138. An important finding was that there were
patches of homogeneous hyaline material in the intersti-
tium and vascular walls (Figure 3A), which was verified
to be amyloid protein by Congon-red staining (Figure
3C). Immunoassay confirmed that the deposit was posi-
tive for kappa but negative for lambda and serum amy-
loid A protein (Figure 3D-E). The patient was diagnosed
as CLL with systemic AL amyloidosis.
Because of unknown reason of worsening of proteinuria
and decreasing of the Alb down to 29 g/l after 2 courses
of combinative chemotherapy including 2 mg chlorambu-
cil and 30 mg prednisone, a kidney biopsy was performed.
The patient’s renal tissue submitted for light microscopy
consisted of two cores of renal cortex and medulla con-
taining 35 glomeruli. There was no global or segmental
sclerosis. All glomeruli showed diffused, eosinophilic and
homogeneous material in mesangial area replacing the
normal mesangial matrix (Figure 4A). Some extended into
the peripheral capillary walls and appeared as large suben-
dothelial deposits or even seemed to be located in the
capillary lumen. The deposits were amyloid as shown by
strong Congo-red positive staining (Figure 4B) and bright
apple green birefringence under polarized light (Figure
4C). The same deposits were found in the interstitium,
peritubular space and blood vessel walls. Immunohisto-
chemistry showed that the amyloid was kappa positive but
negative for lambda and serum amyloid A protein. Only
mild focal tubular atrophy was found. Clusters of lympho-
cyte-like cells which were CD5 and CD20 positive infil-
trated in renal interstitium, occupying less than 30% of the
area of the cortical tissue examined (Figure 4D and 4E).
Figure 1 Flow cytometric analysis of the bone marrow aspiration. The proliferated lymphocytes were positive for CD5, CD20, CD19 and
kappa light chain.
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The small arteries exhibited mild fibrointimal thickening
and the arterioles appeared segmental hyalinosis. Immu-
nofluorescence staining showed faint staining of IgG and
IgM along the peripheral capillary in glomeruli while IgA,
C3, C1q and fibrinogen were negative. Non-branched
fibrils with 10 nm-diameters were detected in mesangium
and subendothelial area (Figure 4F) by electronic micro-
scopy. All these histological changes indicated a direct
infiltration of the tumor cells in the renal parenchyma
together with AL amyloidosis.
Treatment and following-up
Chemotherapy was given by combination of 44 mg fludar-
abine and 20 mg dexamethasone from July 24, 2008
to September 26, 2008 for 3 courses of treatment. After
that, the lymph nodes size decreased and the edema
was dramatically ameliorated with decreased serum Cr
(200 μmol/L), increased serum albumin (39.96 g/L),
declined serum IgM level (2.38 g/L) and slightly reduced
24-hour urinary protein excretion (4.22 g/24 h). However,
the patient developed a severe bone marrow depression
defined by markedly reduced blood cell count (erythro-
cytes: 1.66 × 1012/L, leukocytes: 0.62 × 109/L, platelet:
21 × 109/L). Then the chemotherapy regimen was adjusted
(fludarabine 50 mg, CTX 0.3 g and rituximab 600 mg).
After 3 courses of treatment from Nov 27, 2008 to Feb 19,
2009, the patient achieved a satisfactory hematologic
response. His serum IgM concentration gradually
decreased to the normal level and the monoclonal immu-
noglobulin was undetectable by serum immunofixation
electrophoresis. At the same time, the patient experienced
a gradual improvement in clinical status and decrease in
the proteinuria and serum creatine. His renal function,
urinary protein and serum C3 level were recovered
entirely in Sept 2009 (24-hour urinary protein excretion:
139.20 mg/24 h, urine routine test: negative, serum Cr:
121.00 μmol/L, serum C3 level 0.96 g/L).
Discussion
Proteinuria caused by direct infiltration of neoplastic
cells is generally mild. Severe proteinuria or even
nephrotic syndrome often suggests glomerular involve-
ment [7,10]. Though CLL is rarely complicated with
nephrotic syndrome, a spectrum of glomerular diseases
including light chain deposition disease (LCDD), AL,
membranoproliferative glomerulonephritis (MPGN) [11],
membrane nephropathy (MN) and minimal change dis-
ease (MCD) have been reported, which suggests the pre-
sence of various pathogenesis pathways of CLL-
associated nephrotic syndrome[2,7,11-13]. The glomeru-
lar injuries may be directly caused by the lymphoplas-
macytic neoplasm through a paraprotein deposition
process which finally results in amyloidosis or monoclo-
nal immunoglobulin deposition disease or the indirect
immune-mediated mechanisms may also be involved. In
our case, the monoclonal Ig light chain detected in the
sera was the same class as that found on the surface
membrane of lymphocytes and the amyloid in the kid-
ney and lymph node, indicating that the monoclonal Ig
originated from the proliferating cells. Based on this
finding as well as the histopathological observations, we
made a diagnosis of CLL associated AL amyloidosis.
The reason that we could not detect monoclonal Ig
light chain in the lymphocytic cells by immunohisto-
chemistry may be ascribed to the inaccessibility of epi-
tope after tissue fixation.
Histologically, the leukaemic infiltratation in the kidney
can be nodular or interstitial in CLL. In this patient, both
patterns were observed. When the infiltration is nodular,
especially when there are clusters of cells around sclerotic
glomeruli or atrophic tubules, it is important to determine
whether it is tumor infiltration leading to their destruction
or is only local inflammation secondary to glomerular sce-
lerosis and tubular atrophy caused by other glomerulopa-
thies. The mixture of various inflammatory cells generally
Figure 2 Computed tomography scanning of the neck, chest and abdomen (A). Enlargement of numerous lymph nodes in the neck. (B).
Numerous enlarged lymph nodes in axillary space. (C) Enlargement and confluence of lymph nodes in the peritoneal cavity.
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indicates the secondary local inflammatory response, while
the monotonous appearance of the cells usually suggests
tumor infiltration. But when it comes to a biopsy speci-
men, it is difficult to distinguish both situations due to the
local distribution of the infiltration. In this regard, further
immunohistochemical examinations should be applied.
In general, leukemic infiltration in the kidney should be
considered when a patient with CLL presents with renal
impairment. This kind of patients usually responds well to
chemotherapy as seen in our case [8,14,15].
Figure 3 Photomicrographs of histological changes of the affected lymph node. (A). Lymph node involved showing diffuse small
lymphocyte-like cells and patches of homogenous materials in the dark background of proliferating cells. (HE staining×400). (B) The proliferating
cells are CD5 positive by immunohistochemistry (×200). (C). The deposit was strongly Congon-Red positive. (×200). (D). Strong positivity of 
light chain demonstrated by immunohistochemistry (×100). (E). The deposit was completely negative for llight chain. (×200).
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Figure 4 Photomicrographs of histological changes of the renal biopsy. (A) Renal biopsy illustrated small lymphocyte-like cell infiltrate in
the interstitial tissue. The glomeruli showed amorphous eosinophilic material in the meangium and extending to the peripheral capillary walls
leading the obliteration of segmental capillary loop. Foci of deposition were found in the interstitial and peritubular space. (HE staining×200). (B).
Salmon pink staining of the glomeruli with Congo red staining.(×400). (C). Apple green birefringence was detected under polarized light (×400).
(D) Uniform small lymphoid cell infiltrate in a nodular pattern around a sclerotic glomerulus. (HE staining×200). (E) The infiltrating cells in the
interstitium were CD20 positive by immunohistochemistry (×200). (F) Non-branched and randomly arranged fine fibrils in a diameter of 10 nm
were found in the glomerular mesangial area (×37000).
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AL amyloidosis can be complicated with any clonal B
cell dyscrasia, especially plasma cell dyscrasia. The mis-
folded monoclonal free light chains deposited in the
extracellular space in a fibrillar form which are very
hard to be absorbed. Accumulation of these fibrils in
the kidney causes progressive renal impairment with
proteinuria, even renal failure. It is well known that
most amyloid depositions associated with plasma disor-
ders are lambda-light chains [16]. On the contrary, in
AL amyloid caused by CLL, the monoclonal light chains
detected are predominantly kappa type as in our case
[3,5]. Though AL amyloidosis caused by plasma cell dys-
crasia often has a poor prognosis with a median survival
of 35.2 months from diagnosis due to the poor response
to chemotherapy [17], CLL-associated AL amyloidosis
were reported to be significantly alleviated and obtained
a prolonged survival of more than 7 years [2]. As with
our patient, his proteinuria decreased very slowly and
did not resolve until one year after he obtained hemato-
logic remission. This is believed to be associated with
the reduced production of amyloidogenic light chains so
that the clearance of existing deposits exceeds the rate
of deposition. Those deposited amyloids were gradually
mobilized and cleared by the body.
Another interesting finding is that the serum concen-
tration of C3 in our patient changed significantly after
chemotherapy. It was in the lowest level when the
patient was in acute phase and the serum IgM was high.
With the decrease of serum IgM after treatment, it
recovered to the normal level, indicating that impaired
complement system might be involved in the pathogen-
esis of CLL and its complications [18].
Conclusion
We herein first reported a rare case of nephrotic syn-
drome combined with acute renal failure caused by
CLL. From our patient and few cases reported in the lit-
erature, we suggest that AL amyloidosis should be con-
sidered in CLL patients presenting with proteinuria or
nephrotic syndrome. AL amyloidosis associated with
CLL may have a more favorable prognosis than those
caused by multiple myeloma due to a better response to
chemotherapy. Further investigations are needed to bet-
ter clarify the clinical outcomes and prognosis of this
unusual complication of CLL and to better understand
the pathological and molecular mechanisms of CLL-
induced nephrotic syndrome.
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